FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006659599> ?p ?o ?g. }

• W2006659599 endingPage "3862" @default.
• W2006659599 startingPage "3854" @default.
• W2006659599 abstract "Abstract Context: Somatostatin reduces LH, GH, and insulin, and somatostatin receptors are present at the ovarian level; somatostatin analogs are thus potential candidates for treatment of the polycystic ovary syndrome (PCOS). Objective: The purpose of this study was to evaluate the effect of octreotide-LAR, a long-acting somatostatin analog, in anovulatory abdominal obese women with PCOS. Design: A single-blind, placebo-controlled study was performed, lasting for 7 months. Setting: The patients were ambulatory throughout the study. Patients: Twenty PCOS subjects were enrolled. Eighteen completed the study. Interventions: A low-calorie diet was given during the first month, a low-calorie diet plus octreotide-LAR (10 mg; n = 10 subjects) or placebo (n = 10 subjects) was then given, with one im injection every 28 d (for 6 months). Main Outcome Measures: The main outcome measures were clinical features, computerized tomography measurement of fat distribution, androgens, GH, IGF-I, IGF-binding proteins (IGFBPs), fasting and glucose-stimulated insulin, and ovulation. Results: Octreotide had no additional effect in reducing body fat or improving fat distribution than placebo. Conversely, octreotide produced an additional decrease in fasting (P = 0.018) and glucose-stimulated (P = 0.038) insulin levels, an increase in IGFBP-2 (P = 0.042) and IGFBP-3 (P = 0.047), and an improvement in hirsutism (P = 0.004). Moreover, a trend toward greater reductions in testosterone (P = 0.061) and androstenedione (P = 0.069) was observed in women treated with octreotide-LAR compared with those given placebo. All women treated with octreotide ovulated at the end of the study compared with only one of those receiving placebo (P &lt; 0.001). Conclusions: Octreotide-LAR may be usefully applied to hypocalorically dieting, abdominal obese PCOS women to improve hyperandrogenism and the insulin-IGF-I system. Restoration of ovulatory menstrual cycles appears to be another advantage of this treatment." @default.
• W2006659599 created "2016-06-24" @default.
• W2006659599 creator A5027234378 @default.
• W2006659599 creator A5035241479 @default.
• W2006659599 creator A5043923233 @default.
• W2006659599 creator A5044754717 @default.
• W2006659599 creator A5048808735 @default.
• W2006659599 creator A5059235123 @default.
• W2006659599 creator A5065445113 @default.
• W2006659599 creator A5070321335 @default.
• W2006659599 creator A5085813854 @default.
• W2006659599 creator A5086973330 @default.
• W2006659599 date "2005-07-01" @default.
• W2006659599 modified "2023-09-27" @default.
• W2006659599 title "Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome" @default.
• W2006659599 cites W1587263644 @default.
• W2006659599 cites W1972889443 @default.
• W2006659599 cites W1988824109 @default.
• W2006659599 cites W2006011837 @default.
• W2006659599 cites W2021089886 @default.
• W2006659599 cites W2021450389 @default.
• W2006659599 cites W2044970382 @default.
• W2006659599 cites W2062244462 @default.
• W2006659599 cites W2062458291 @default.
• W2006659599 cites W2071310612 @default.
• W2006659599 cites W2077815106 @default.
• W2006659599 cites W2097146819 @default.
• W2006659599 cites W2098247759 @default.
• W2006659599 cites W2101440848 @default.
• W2006659599 cites W2102239047 @default.
• W2006659599 cites W2108112484 @default.
• W2006659599 cites W2111800194 @default.
• W2006659599 cites W2114277230 @default.
• W2006659599 cites W2115315666 @default.
• W2006659599 cites W2127009736 @default.
• W2006659599 cites W2133795831 @default.
• W2006659599 cites W2145281883 @default.
• W2006659599 cites W2148300334 @default.
• W2006659599 cites W2154063651 @default.
• W2006659599 cites W2160234571 @default.
• W2006659599 cites W2168780440 @default.
• W2006659599 cites W2169689389 @default.
• W2006659599 cites W2201798686 @default.
• W2006659599 cites W2314633857 @default.
• W2006659599 cites W2324024668 @default.
• W2006659599 cites W2344542684 @default.
• W2006659599 cites W2407813863 @default.
• W2006659599 cites W4256605237 @default.
• W2006659599 doi "https://doi.org/10.1210/jc.2004-2490" @default.
• W2006659599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15827099" @default.
• W2006659599 hasPublicationYear "2005" @default.
• W2006659599 type Work @default.
• W2006659599 sameAs 2006659599 @default.
• W2006659599 citedByCount "42" @default.
• W2006659599 countsByYear W20066595992012 @default.
• W2006659599 countsByYear W20066595992013 @default.
• W2006659599 countsByYear W20066595992014 @default.
• W2006659599 countsByYear W20066595992015 @default.
• W2006659599 countsByYear W20066595992016 @default.
• W2006659599 countsByYear W20066595992017 @default.
• W2006659599 countsByYear W20066595992018 @default.
• W2006659599 countsByYear W20066595992019 @default.
• W2006659599 countsByYear W20066595992020 @default.
• W2006659599 countsByYear W20066595992021 @default.
• W2006659599 countsByYear W20066595992022 @default.
• W2006659599 countsByYear W20066595992023 @default.
• W2006659599 crossrefType "journal-article" @default.
• W2006659599 hasAuthorship W2006659599A5027234378 @default.
• W2006659599 hasAuthorship W2006659599A5035241479 @default.
• W2006659599 hasAuthorship W2006659599A5043923233 @default.
• W2006659599 hasAuthorship W2006659599A5044754717 @default.
• W2006659599 hasAuthorship W2006659599A5048808735 @default.
• W2006659599 hasAuthorship W2006659599A5059235123 @default.
• W2006659599 hasAuthorship W2006659599A5065445113 @default.
• W2006659599 hasAuthorship W2006659599A5070321335 @default.
• W2006659599 hasAuthorship W2006659599A5085813854 @default.
• W2006659599 hasAuthorship W2006659599A5086973330 @default.
• W2006659599 hasBestOaLocation W20066595991 @default.
• W2006659599 hasConcept C126322002 @default.
• W2006659599 hasConcept C134018914 @default.
• W2006659599 hasConcept C142724271 @default.
• W2006659599 hasConcept C151730666 @default.
• W2006659599 hasConcept C204787440 @default.
• W2006659599 hasConcept C27081682 @default.
• W2006659599 hasConcept C2776297358 @default.
• W2006659599 hasConcept C2776371013 @default.
• W2006659599 hasConcept C2777391703 @default.
• W2006659599 hasConcept C2779306644 @default.
• W2006659599 hasConcept C2779343474 @default.
• W2006659599 hasConcept C2781025020 @default.
• W2006659599 hasConcept C3018442814 @default.
• W2006659599 hasConcept C71924100 @default.
• W2006659599 hasConcept C86803240 @default.
• W2006659599 hasConceptScore W2006659599C126322002 @default.
• W2006659599 hasConceptScore W2006659599C134018914 @default.
• W2006659599 hasConceptScore W2006659599C142724271 @default.
• W2006659599 hasConceptScore W2006659599C151730666 @default.
• W2006659599 hasConceptScore W2006659599C204787440 @default.

• next